Scinopharm Taiwan (TPE:1789) Change In Receivables : NT$86 Mil (TTM As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Scinopharm Taiwan Change In Receivables?

Scinopharm Taiwan's change in receivables for the quarter that ended in Mar. 2025 was NT$181 Mil. It means Scinopharm Taiwan's Accounts Receivable declined by NT$181 Mil from Dec. 2024 to Mar. 2025 .

Scinopharm Taiwan's change in receivables for the fiscal year that ended in Dec. 2024 was NT$158 Mil. It means Scinopharm Taiwan's Accounts Receivable declined by NT$158 Mil from Dec. 2023 to Dec. 2024 .

Scinopharm Taiwan's Accounts Receivable for the quarter that ended in Mar. 2025 was NT$447 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Scinopharm Taiwan's Days Sales Outstanding for the three months ended in Mar. 2025 was 59.37.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Scinopharm Taiwan's liquidation value for the three months ended in Mar. 2025 was NT$2,954 Mil.

Scinopharm Taiwan Change In Receivables Historical Data

The historical data trend for Scinopharm Taiwan's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scinopharm Taiwan Change In Receivables Chart

Scinopharm Taiwan Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

195.78

69.98

-259.61

-154.87

158.29

Scinopharm Taiwan Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															253.31	63.85	21.00	-179.87	180.80

Scinopharm Taiwan Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$86 Mil.

Scinopharm Taiwan (TPE:1789) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Scinopharm Taiwan's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	446.597	/	686.365	*	91
=	59.37

2. In Ben Graham's calculation of liquidation value, Scinopharm Taiwan's accounts receivable are only considered to be worth 75% of book value:

Scinopharm Taiwan's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	3097.705	-	1374.606	+	0.75 * 446.597	+	0.5 * 1792.432
=	2,954

Scinopharm Taiwan Change In Receivables Related Terms

Thank you for viewing the detailed overview of Scinopharm Taiwan's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Scinopharm Taiwan Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Scinopharm Taiwan Ltd (TPE:1789) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Nan-Ke 8th Road, Southern Taiwan Science Park, Shan-Hua, Tainan, TWN, 74144

Website

https://www.scinopharm.com

Scinopharm Taiwan Ltd is a specialty and generic drug manufacturing company. The company is primarily engaged in the manufacturing of medicines, chemicals, biological technology services, active pharmaceutical ingredients, albumin medicines, injections, and new small molecule drugs. Schinopharm also conducts consulting and technical services. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. The Company's sales revenue mainly arises from the manufacture and sales of Active Pharmaceutical Ingredient and injection products.

Scinopharm Taiwan Headlines

No Headlines